Meet our experienced team

Our Leadership Team, Board of Directors and Scientific Advisors collectively bring over two hundred years of drug development and execution experience to Attovia. We harness this power to bring treatments to patients where none exist and to create best-in-class options where current solutions fall short. Together, we envision a world where no patient is left behind.

Meet Our Experienced Team

Our Leadership Team, Board of Directors and Scientific Advisors collectively bring over two hundred years of drug development and execution experience to Attovia. We harness this power to bring treatments to patients where none exist and to create best-in-class options where current solutions fall short. Together, we envision a world where no patient is left behind.

Leadership Team

Leadership Team

Tao Fu
Tao Fu, MBA, M.S.
Chief Executive Officer
chen
Hubert Chen, M.D., M.P.H.
Chief Medical Officer
Zaneta Odrowaz
Zaneta Odrowaz, Ph.D.
Chief Business Officer
petter_vieby
Petter Veiby, Ph.D.
Chief Scientific Officer
Hangjun_Zhan
Hangjun Zhan, Ph.D.
Chief Technology Officer
David_Bellovin
David Bellovin, Ph.D.
Vice President, Discovery and Translational Biology
Veit_Schmelmer
Veit Schmelmer, Ph.D.
Vice President of Project Management and Portfolio Strategy

Board of Directors

Board of Directors

Jamie Topper, M.D., Ph.D.
Chairman
Tao Fu, MBA, M.S.
Director
Yuling Luo, Ph.D.
Director
Aaron Royston, M.D., MBA
Director

Scientific Advisors

Scientific Advisors

richardheyman
Richard Heyman, Ph.D.
Chairman of the Board
Oric Pharmaceuticals and RayzeBio
david king
David King, Ph.D.
CSO and Co-Founder
Lassen Therapeutics
luisa salter
Luisa Salter-Cid, Ph.D.
CSO
Pioneering Medicines
silverberg
Jonathan Silverberg, M.D., Ph.D.
Director of Clinical Research
The George Washington University School of Medicine and Health Sciences